Popular anti-diabetes and obesity drug Mounjaro, containing the active ingredient tirzepatide, is now available in India in a ...

Constipation in pets is a common issue that affects many animals, particularly dogs and cats. It is characterized by ...

Punjab is at the 27th place among 28 states and eight union territories in the country. Ironically, the state could achieve ...

Neuroscientists used cognitive tests and brain scans to reveal the benefits of a surprising addition to your morning meal.

Two experts mentioned in the lawsuit argued that the veterans hospital and, in turn, the U.S. government, were negligent for ...

Primary care clinicians are often the most accessible to patients and play a crucial role in the early detection and ...

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with a rapidly increasing global prevalence. It is primarily ...

Type 1, not type 2 diabetes, is autoimmune. There are other rarer autoimmune types. Learn about type 2 diabetes, immunity, ...

Empagliflozin patent expiration in India leads to affordable treatment for diabetes, heart failure, and kidney disease.

Empagliflozin is an SGLT-2 (Sodium-Glucose Co-Transporter-2) inhibitor indicted for use in the treatment of type-2 diabetes mellitus, chronic kidney disease (CKD) and chronic heart failure (HF).